Pulsed Electromagnetic Fields Combined with Adipose-Derived Stem Cells Protect Ischemic Myocardium by Regulating Mir-20A-5p/e2f1/p73 Signaling.

Yang Wang,Li Chen,Lu Wang,Gaiqin Pei,Hongxin Cheng,Qing Zhang,Shiqi Wang,Danrong Hu,Yong He,Chengqi He,Chenying Fu,Quan Wei

DOI: https://doi.org/10.1093/stmcls/sxad037

IF: 5.845

2023-01-01

Stem Cells

Abstract:Myocardial infarction (MI) is a serious threat to human health. Although monotherapy with pulsed electromagnetic fields (PEMFs) or adipose-derived stem cells (ADSCs) has been reported to have positive effect on the treatment of MI, a satisfactory outcome has not yet been achieved. In recent years, combination therapy has attracted widespread interest. Herein, we explored the synergistic therapeutic effect of combination therapy with PEMFs and ADSCs on MI and found that the combination of PEMFs and ADSCs effectively reduced infarct size, inhibited cardiomyocyte apoptosis and protected the cardiac function in mice with MI. In addition, bioinformatics analysis and RT-qPCR showed that the combination therapy could affect apoptosis by regulating the expression of miR-20a-5p. A dual-luciferase reporter gene assay also confirmed that the miR-20a-5p could target E2F transcription factor 1 (E2F1) and inhibit cardiomyocyte apoptosis by regulating the E2F1/p73 signaling pathway. Therefore, our study systematically demonstrated the effectiveness of combination therapy on the inhibition of cardiomyocyte apoptosis by regulating the miR-20a-5p/E2F1/p73 signaling pathway in mice with MI. Thus, our study underscored the effectiveness of the combination of PEMFs and ADSCs and identified miR-20a-5p as a promising therapeutic target for the treatment of MI in the future.